4 weeks Eli Lilly Plummets On Rare — But ‘Big’ — Sales Miss For Diabetes, Weight-Loss DrugsInvestor's Business Daily
Eli Lilly stock crashed Wednesday after the pharma giant cut its 2024 outlook following a “big” miss for its diabetes and weight-loss drugs.
The post Eli Lilly Plummets On Rare — But 'Big' — Sales Miss For Diabetes, Weight-Loss Drugs appeared…